Income Investors Face Choices Amid Rising Treasury Yields
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 12 2026
0mins
Source: Fool
- UnitedHealth Membership Loss: The company anticipates losing up to 2.8 million members due to rising medical costs, resulting in a 20% drop in stock price following its Q4 earnings release, reflecting market concerns over profitability.
- Ryman's Performance Decline: Ryman Hospitality Properties reported a 15.5% drop in adjusted funds from operations (AFFO) per unit in Q3, primarily due to planned renovations and an increase in short-term cancellations, although bookings are up nearly 8% this year.
- ONEOK's Significant Earnings Growth: ONEOK's adjusted EBITDA surged 37% year-over-year to $2.1 billion in Q3, driven by contributions from EnLink and Medallion assets, showcasing its enhanced integration capabilities.
- Dividend Safety Analysis: Despite ongoing uncertainties, UnitedHealth's 3.2% dividend remains secure, with last year's free cash flow reaching $16 billion, nearly double the dividend payout, indicating strong financial health.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
Current: 324.630
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UNITEDHEALTH STOCK RISES 5.2% IN PREMARKET TRADING FOLLOWING Q1 PROFIT BEAT
- Market Performance: United Health shares increased by 5.2% in pre-market trading following the release of their Q1 profit report.
- Profit Exceeding Estimates: The company's reported profits were above analysts' expectations, contributing to the positive market reaction.
See More
UnitedHealth Group's Outlook Analysis
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
UnitedHealthcare Expands Rural Healthcare Initiatives Nationwide
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
UnitedHealth Group Announces $2B Stock Buyback Plan
- Stock Buyback Plan: UnitedHealth Group announced a plan to repurchase at least $2 billion of its common stock by the end of Q2 2026, aimed at enhancing shareholder value and boosting market confidence.
- OptumUK Sale Proceeds: The company completed the sale of its OptumUK business, generating $400 million in net proceeds, which will be committed to supporting initiatives by the United Health Foundation, further solidifying its image of corporate social responsibility.
- Earnings Beat Expectations: UnitedHealth reported a non-GAAP EPS of $7.23, exceeding expectations by $0.63, with revenue of $111.72 billion surpassing estimates by $2.06 billion, showcasing the company's strong financial performance and competitive position in the market.
- Payment Process Optimization: The company has eliminated prior authorization for rural healthcare providers, speeding up payment processes, which will enhance service efficiency and improve accessibility to healthcare services.
See More
UnitedHealth Reports Strong Q1 Earnings, Raises 2026 Outlook
- Earnings Beat: UnitedHealth's Q1 non-GAAP EPS of $7.23 exceeded expectations by $0.63, with revenues of $111.72 billion reflecting a 2.0% year-over-year increase, surpassing estimates by $2.06 billion, indicating robust profitability and market demand.
- Raised Earnings Outlook: The company raised its full-year 2026 earnings outlook to greater than $17.35 per share, with adjusted earnings expected to exceed $18.25 per share compared to the consensus of $17.87, reflecting strong confidence in future growth.
- Improved Medical Cost Ratio: The medical cost ratio for Q1 was 83.9%, down 90 basis points from Q1 2025, demonstrating significant progress in cost control and laying a foundation for future profitability growth.
- Strong Optum Performance: Optum served over 122 million consumers, generating revenues of $63.7 billion and earnings of $3.3 billion, reflecting a 5.2% margin, showcasing its strong competitive position and market share in the healthcare services sector.
See More
Buffett Retires, Abel Takes Over as CEO of Berkshire Hathaway
- Leadership Transition: Warren Buffett retired on December 31, 2025, with Greg Abel stepping in to manage Berkshire Hathaway's $320 billion investment portfolio, marking a significant new era for the company.
- Investment Concentration: Abel's portfolio is heavily weighted, with 10 core holdings accounting for nearly 79% of assets, including Apple at $60 billion, highlighting the company's focus on high-quality assets and long-term growth potential.
- Sustainable Competitive Advantages: Among the 20 billion-dollar investments Abel oversees, many companies like Visa and Sirius XM operate as legal monopolies, ensuring stable revenue streams and risk resilience, reflecting Berkshire's investment strategy.
- Smaller Holdings Adjustment: Abel also manages 18 relatively smaller investments, with significant reductions like the 77% cut in Amazon's stake, indicating a focus on optimizing the portfolio and potentially paving the way for future trading opportunities.
See More
UNITEDHEALTH STOCK RISES 5.2% IN PREMARKET TRADING FOLLOWING Q1 PROFIT BEAT
- Market Performance: United Health shares increased by 5.2% in pre-market trading following the release of their Q1 profit report.
- Profit Exceeding Estimates: The company's reported profits were above analysts' expectations, contributing to the positive market reaction.
See More
UnitedHealth Group's Outlook Analysis
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
UnitedHealthcare Expands Rural Healthcare Initiatives Nationwide
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
UnitedHealth Group Announces $2B Stock Buyback Plan
- Stock Buyback Plan: UnitedHealth Group announced a plan to repurchase at least $2 billion of its common stock by the end of Q2 2026, aimed at enhancing shareholder value and boosting market confidence.
- OptumUK Sale Proceeds: The company completed the sale of its OptumUK business, generating $400 million in net proceeds, which will be committed to supporting initiatives by the United Health Foundation, further solidifying its image of corporate social responsibility.
- Earnings Beat Expectations: UnitedHealth reported a non-GAAP EPS of $7.23, exceeding expectations by $0.63, with revenue of $111.72 billion surpassing estimates by $2.06 billion, showcasing the company's strong financial performance and competitive position in the market.
- Payment Process Optimization: The company has eliminated prior authorization for rural healthcare providers, speeding up payment processes, which will enhance service efficiency and improve accessibility to healthcare services.
See More
UnitedHealth Reports Strong Q1 Earnings, Raises 2026 Outlook
- Earnings Beat: UnitedHealth's Q1 non-GAAP EPS of $7.23 exceeded expectations by $0.63, with revenues of $111.72 billion reflecting a 2.0% year-over-year increase, surpassing estimates by $2.06 billion, indicating robust profitability and market demand.
- Raised Earnings Outlook: The company raised its full-year 2026 earnings outlook to greater than $17.35 per share, with adjusted earnings expected to exceed $18.25 per share compared to the consensus of $17.87, reflecting strong confidence in future growth.
- Improved Medical Cost Ratio: The medical cost ratio for Q1 was 83.9%, down 90 basis points from Q1 2025, demonstrating significant progress in cost control and laying a foundation for future profitability growth.
- Strong Optum Performance: Optum served over 122 million consumers, generating revenues of $63.7 billion and earnings of $3.3 billion, reflecting a 5.2% margin, showcasing its strong competitive position and market share in the healthcare services sector.
See More
Buffett Retires, Abel Takes Over as CEO of Berkshire Hathaway
- Leadership Transition: Warren Buffett retired on December 31, 2025, with Greg Abel stepping in to manage Berkshire Hathaway's $320 billion investment portfolio, marking a significant new era for the company.
- Investment Concentration: Abel's portfolio is heavily weighted, with 10 core holdings accounting for nearly 79% of assets, including Apple at $60 billion, highlighting the company's focus on high-quality assets and long-term growth potential.
- Sustainable Competitive Advantages: Among the 20 billion-dollar investments Abel oversees, many companies like Visa and Sirius XM operate as legal monopolies, ensuring stable revenue streams and risk resilience, reflecting Berkshire's investment strategy.
- Smaller Holdings Adjustment: Abel also manages 18 relatively smaller investments, with significant reductions like the 77% cut in Amazon's stake, indicating a focus on optimizing the portfolio and potentially paving the way for future trading opportunities.
See More
